Prothena Corp. Company Profile (NASDAQ:PRTA)

About Prothena Corp.

Prothena Corp. logoProthena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis (PRX003). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. Its pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion. NEOD001 is a monoclonal antibody that specifically targets the amyloid that accumulates in AL amyloidosis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRTA
  • CUSIP:
Key Metrics:
  • Previous Close: $50.03
  • 50 Day Moving Average: $53.05
  • 200 Day Moving Average: $43.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.53
  • P/E Growth: 0.09
  • Market Cap: $1.72B
  • Outstanding Shares: 34,395,000
  • Beta: 2.39
Additional Links:
Companies Related to Prothena Corp.:

Analyst Ratings

Consensus Ratings for Prothena Corp. (NASDAQ:PRTA) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $76.60 (53.11% upside)

Analysts' Ratings History for Prothena Corp. (NASDAQ:PRTA)
Show:
DateFirmActionRatingPrice TargetDetails
8/4/2016Barclays PLCBoost Price TargetOverweight$60.00 -> $70.00View Rating Details
8/3/2016WedbushReiterated RatingOutperform$77.00View Rating Details
7/18/2016Royal Bank Of CanadaReiterated RatingOutperform$95.00View Rating Details
7/12/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
3/15/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$77.00View Rating Details
6/19/2015Ladenburg ThalmannBoost Price TargetBuy$49.00 -> $57.00View Rating Details
12/5/2014Bank of America Corp.DowngradeNeutral -> UnderperformView Rating Details
12/4/2014Citigroup Inc.Lower Price TargetBuy$60.00 -> $37.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Prothena Corp. (NASDAQ:PRTA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016        
8/2/2016Q2($0.91)($1.18)$0.39 million$0.33 millionViewN/AView Earnings Details
5/3/2016Q116($0.77)($0.81)ViewN/AView Earnings Details
2/18/2016Q215($0.81)($0.76)$0.39 million$0.31 millionViewListenView Earnings Details
11/2/2015($0.66)($0.73)ViewN/AView Earnings Details
8/4/2015Q2($0.56)($0.59)ViewN/AView Earnings Details
5/5/2015($0.59)($0.55)ViewN/AView Earnings Details
3/5/2015Q414($0.66)($0.48)$1.20 million$2.00 millionViewN/AView Earnings Details
11/3/2014Q314($0.60)($0.48)$1.13 million$1.50 millionViewN/AView Earnings Details
8/4/2014Q214$0.06$15.10 millionViewN/AView Earnings Details
5/6/2014$0.81$0.78ViewN/AView Earnings Details
3/6/2014Q113($0.52)ViewN/AView Earnings Details
3/28/2013Q412($0.82)$0.13 million$0.58 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Prothena Corp. (NASDAQ:PRTA)
Current Year EPS Consensus Estimate: $-4.43 EPS
Next Year EPS Consensus Estimate: $-4.34 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.82)($0.82)($0.82)
Q2 20162($0.90)($0.90)($0.90)
Q3 20162($1.27)($0.99)($1.13)
Q4 20162($1.39)($1.13)($1.26)
Q1 20171($0.38)($0.38)($0.38)
Q2 20171($1.45)($1.45)($1.45)
Q3 20171($1.52)($1.52)($1.52)
Q4 20171($1.58)($1.58)($1.58)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Prothena Corp. (NASDAQ:PRTA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Prothena Corp. (NASDAQ:PRTA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/20/2016Arthur W HomanInsiderSell9,375$52.14$488,812.50View SEC Filing  
5/24/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  
4/13/2016Karin L WalkerInsiderSell4,000$45.11$180,440.00View SEC Filing  
4/4/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  
1/13/2016Karin L. WalkerinsiderSell4,000$50.96$203,840.00View SEC Filing  
12/9/2015Tara NickersoninsiderSell10,000$66.17$661,700.00View SEC Filing  
12/9/2015Tran NguyenCFOSell30,000$66.17$1,985,100.00View SEC Filing  
12/1/2015Dennis J. SelkoeDirectorSell3,125$68.74$214,812.50View SEC Filing  
11/27/2015Christopher S. HenneyDirectorSell5,000$75.00$375,000.00View SEC Filing  
11/25/2015Lars EkmanDirectorSell30,000$73.35$2,200,500.00View SEC Filing  
11/13/2015Martin KollerinsiderSell30,000$65.03$1,950,900.00View SEC Filing  
11/2/2015Arthur W. HomaninsiderSell3,125$52.14$162,937.50View SEC Filing  
10/29/2015Christopher S. HenneyDirectorSell5,000$55.00$275,000.00View SEC Filing  
9/9/2015Tara NickersoninsiderSell10,000$56.06$560,600.00View SEC Filing  
9/2/2015Martin KollerinsiderSell30,000$55.56$1,666,800.00View SEC Filing  
9/1/2015Dennis J. SelkoeDirectorSell3,125$55.45$173,281.25View SEC Filing  
8/20/2015Dale B. SchenkCEOSell30,000$56.65$1,699,500.00View SEC Filing  
8/12/2015Karin L WalkerInsiderSell7,000$62.06$434,420.00View SEC Filing  
6/9/2015Tara NickersonInsiderSell12,000$44.41$532,920.00View SEC Filing  
3/20/2015Tara NickersonInsiderSell13,000$39.99$519,870.00View SEC Filing  
3/9/2015Dennis J SelkoeDirectorSell3,125$25.56$79,875.00View SEC Filing  
8/12/2014Karin L WalkerInsiderSell2,500$20.74$51,850.00View SEC Filing  
8/7/2014Arthur W HomanInsiderBuy2,000$19.12$38,240.00View SEC Filing  
6/6/2014Karin L WalkerInsiderSell8,000$21.58$172,640.00View SEC Filing  
5/12/2014Dale SchenkCEOBuy8,000$20.79$166,320.00View SEC Filing  
5/12/2014Tara NickersonInsiderBuy1,656$21.00$34,776.00View SEC Filing  
5/9/2014Gene KinneyInsiderBuy2,500$19.54$48,850.00View SEC Filing  
5/9/2014Tran NguyenCFOBuy2,200$19.61$43,142.00View SEC Filing  
2/3/2014Co Plc Perrigomajor shareholderSell3,182,253$24.96$79,429,034.88View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Prothena Corp. (NASDAQ:PRTA)
DateHeadline
investornewswire.com logoWill Prothena Corporation plc (NASDAQ:PRTA) Hit $95 Price Target? - Investor Newswire (NASDAQ:PRTA)
www.investornewswire.com - August 20 at 6:36 PM
finance.yahoo.com logoPROTHENA CORP PLC Financials (NASDAQ:PRTA)
finance.yahoo.com - August 9 at 7:12 PM
capitalcube.com logoETF’s with exposure to Prothena Corp. Plc : August 9, 2016 (NASDAQ:PRTA)
www.capitalcube.com - August 9 at 7:12 PM
fool.com logoWhy Prothena Corp plc Skyrocketed 43% in July (NASDAQ:PRTA)
www.fool.com - August 7 at 10:59 AM
investornewswire.com logoStrong Sell Calls For Prothena Corporation plc (NASDAQ:PRTA) At 0 - Investor Newswire (NASDAQ:PRTA)
www.investornewswire.com - August 6 at 6:59 PM
insidermonkey.com logoHere's A Look At Prothena Corporation PLC (PRTA)'s Upcoming Milestones - Insider Monkey (blog) (NASDAQ:PRTA)
www.insidermonkey.com - August 5 at 7:08 PM
capitalcube.com logoProthena Corp. Plc :PRTA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:PRTA)
www.capitalcube.com - August 5 at 7:08 PM
zacks.com logoProthena (PRTA) Reports Wider-than-Anticipated Loss in Q2 (NASDAQ:PRTA)
www.zacks.com - August 3 at 7:18 PM
News IconHere’s A Look At Prothena Corporation PLC (PRTA)’s Upcoming Milestones (NASDAQ:PRTA)
feedproxy.google.com - August 3 at 3:56 PM
globenewswire.com logoProthena Reports Second Quarter 2016 Financial Results; Provides R&D Update (NASDAQ:PRTA)
globenewswire.com - August 3 at 10:11 AM
twst.com logoProthena Corporation plc: Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update (NASDAQ:PRTA)
www.twst.com - August 2 at 7:16 PM
sg.finance.yahoo.com logoProthena reports 2Q loss (NASDAQ:PRTA)
sg.finance.yahoo.com - August 2 at 7:16 PM
equities.com logoProthena Corporation plc (PRTA) Jumps 7.46% on July 27 - Equities.com (NASDAQ:PRTA)
www.equities.com - July 28 at 10:10 AM
investornewswire.com logoIs $95 Price Target Attainable For Prothena Corporation plc (NASDAQ:PRTA)? - Investor Newswire (NASDAQ:PRTA)
www.investornewswire.com - July 23 at 6:25 PM
News IconProthena Corporation Plc Ord WI (NASDAQ:PRTA) Shorts Decreased by 6.09% After Short Covering - Consumer Eagle (NASDAQ:PRTA)
www.consumereagle.com - July 23 at 10:49 AM
fidaily.com logoInsiders Are Selling – Prothena Corporation plc (NASDAQ:PRTA) (NASDAQ:PRTA)
www.fidaily.com - July 22 at 6:47 PM
News IconChief Legal Officer of Prothena Corporation plc (NASDAQ:PRTA), Homan Arthur W, sells 9,375 shares worth $488,813 (NASDAQ:PRTA)
empowerednews.net - July 22 at 6:47 PM
tradecalls.org logoShares of Prothena Corporation plc (PRTA) Rally 10.79% - Trade Calls (NASDAQ:PRTA)
www.tradecalls.org - July 19 at 7:05 PM
kcregister.com logoHot Alert: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Prothena Corporation plc (NASDAQ:PRTA), Tandem Diabetes ... - KC Register (NASDAQ:PRTA)
www.kcregister.com - July 19 at 5:49 AM
capitalcube.com logoProthena Corp. Plc – Value Analysis (NASDAQ:PRTA) : July 18, 2016 (NASDAQ:PRTA)
www.capitalcube.com - July 18 at 4:12 PM
equities.com logoProthena Corporation plc (PRTA) Drops 8.79% on July 13 - Equities.com (NASDAQ:PRTA)
www.equities.com - July 16 at 10:13 AM
News IconProthena Corporation plc (NASDAQ:PRTA) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:PRTA)
www.engelwooddaily.com - July 14 at 7:12 PM
news.cmlviz.com logoProthena Corporation plc Realized Volatility Hits Extreme Level - CML News (NASDAQ:PRTA)
news.cmlviz.com - July 14 at 7:12 PM
News IconCould Prothena Corporation PLC Recover After Today's Huge Decline? - Consumer Eagle (NASDAQ:PRTA)
www.consumereagle.com - July 14 at 10:34 AM
News IconAnalyst Target and Average Rating Watch: Prothena Corporation plc (NASDAQ:PRTA) - Press Telegraph (NASDAQ:PRTA)
presstelegraph.com - July 14 at 10:34 AM
equities.com logoProthena Corporation plc (PRTA) Jumps 7.39% on July 12 - Equities.com (NASDAQ:PRTA)
www.equities.com - July 14 at 10:34 AM
equities.com logoProthena Corporation plc (PRTA) Jumps 7.39% on July 12 (NASDAQ:PRTA)
www.equities.com - July 12 at 7:10 PM
biz.yahoo.com logoPROTHENA CORP PLC Files SEC form 8-K, Termination of a Material Definitive Agreement (NASDAQ:PRTA)
biz.yahoo.com - July 12 at 5:31 PM
News IconProthena Corporation Plc Ord WI (NASDAQ:PRTA) Short Interest Increased By 3.99% - Press Telegraph (NASDAQ:PRTA)
presstelegraph.com - July 12 at 11:20 AM
News IconWere Analysts Bullish Prothena Corporation PLC (NASDAQ:PRTA) This Week? - Press Telegraph (NASDAQ:PRTA)
presstelegraph.com - July 12 at 11:20 AM
capitalcube.com logoProthena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : July 11, 2016 (NASDAQ:PRTA)
www.capitalcube.com - July 11 at 9:05 AM
investornewswire.com logoIs $95 Within Reach For Prothena Corporation plc (NASDAQ:PRTA)? - Investor Newswire (NASDAQ:PRTA)
www.investornewswire.com - July 10 at 6:14 PM
globenewswire.com logoProthena to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:PRTA)
globenewswire.com - July 8 at 6:57 PM
biz.yahoo.com logoPROTHENA CORP PLC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders (NASDAQ:PRTA)
biz.yahoo.com - July 8 at 4:24 PM
News IconProthena Corporation Plc Ord WI (NASDAQ:PRTA) Sellers Increased By 3.99% Their Shorts - Press Telegraph (NASDAQ:PRTA)
presstelegraph.com - July 8 at 9:50 AM
insidermonkey.com logoProthena Corporation PLC (PRTA)'s Amyloidosis Pipeline In Focus - Insider Monkey (blog) (NASDAQ:PRTA)
www.insidermonkey.com - July 8 at 9:50 AM
fiscalstandard.com logoBroker Outlook For Prothena Corporation Plc (NASDAQ:PRTA) - Fiscal Standard (NASDAQ:PRTA)
www.fiscalstandard.com - July 8 at 9:50 AM
News IconCompany Stock Focus for Prothena Corporation plc (NASDAQ:PRTA): Which Way Will Shares Head? - Press Telegraph (NASDAQ:PRTA)
presstelegraph.com - July 7 at 6:59 PM
marketexclusive.com logoProthena Corporation PLC (NASDAQ:PRTA)'s Amyloidosis Pipeline In Focus - Market Exclusive (NASDAQ:PRTA)
marketexclusive.com - July 7 at 6:59 PM
finanznachrichten.de logoProthena Corporation plc: Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:PRTA)
www.finanznachrichten.de - July 6 at 7:11 PM
publicnow.com logoProthena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:PRTA)
www.publicnow.com - July 6 at 4:11 PM
News IconProthena Corporation PLC (PRTA)’s Amyloidosis Pipeline In Focus (NASDAQ:PRTA)
feedproxy.google.com - July 6 at 2:24 PM
streetinsider.com logoForm 8-K Prothena Corp plc For: Jul 05 (NASDAQ:PRTA)
www.streetinsider.com - July 6 at 11:35 AM
marketexclusive.com logoProthena Corporation PLC (NASDAQ:PRTA)’s Amyloidosis Pipeline In Focus (NASDAQ:PRTA)
marketexclusive.com - July 6 at 11:35 AM
kcregister.com logoToday's Stocks: Prothena Corporation plc (NASDAQ:PRTA), Harley-Davidson, Inc. (NYSE:HOG), Cobalt International ... - KC Register (NASDAQ:PRTA)
www.kcregister.com - July 5 at 11:25 AM
streetinsider.com logoProthena Corp. (PRTA) Announces New Data from NEOD001 Phase 1/2; Organ Systems Improvements Notes - StreetInsider.com (NASDAQ:PRTA)
www.streetinsider.com - July 5 at 11:25 AM
biz.yahoo.com logoPROTHENA CORP PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:PRTA)
biz.yahoo.com - July 5 at 7:34 AM
publicnow.com logoProthena Presents New Data from Phase 1/2 Study of NEOD001 Demonstrating Improvements in Three Organ Systems in Previously-Treated Patients with AL Amyloidosis (NASDAQ:PRTA)
www.publicnow.com - July 5 at 7:11 AM
investornewswire.com logoProthena Corporation plc (NASDAQ:PRTA) Expected to Reach Highs Of $95 - Investor Newswire (NASDAQ:PRTA)
www.investornewswire.com - July 2 at 6:34 PM
equities.com logoProthena Corporation plc (PRTA) Jumps 7.04% on June 28 - Equities.com (NASDAQ:PRTA)
www.equities.com - July 1 at 9:42 AM

Social

Prothena Corp. (NASDAQ:PRTA) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff